Advanced Cell Immunotherapies

We develop CAR-T technologies in treatment of both haematological tumours and solid tumours. This is a break-through and a unique achievement on a world scale, as solid tumours constitute no less than 96% of all malignant tumours.

CAR-T therapies aimed at treating haematological tumours, especially multiple myeloma.

CAR-T therapies aimed at treating solid tumours, especially pancreatic carcinoma, gastric and colorectal carcinoma

Automation of CAR-T production on industrial scale, developed in a consortium with the Silesian University of Technolog

TECHNOLOGIES

Innovations of Polish scientists

4Cell Therapies S.A. develops CAR-T technologies aimed at treating tumours, based on patented solutions. Research and development works are realized in Warsaw and Gliwice by Polish scientists with international experience. READ MORE →

PARTNERS

International licences

Our products are created on the basis of licences acquired from companies and institutions from all over the world, especially the USA and Canada. Among partners of the Company in Poland, we count the National Research Institute of Oncology, the Medical University of Warsaw and the Silesian University of Technology. CZYTAJ →